| Literature DB >> 32964033 |
Pengfei Lei1, Zhan Liao1, Jiang Peng2, Guang Li3, Qian Zhou2, Xiao Xiao2, Chunhua Yang2.
Abstract
The supercapsular percutaneously assisted total hip (SuperPATH) approach is a microinvasive approach that was developed to minimize surgical disruption of soft tissue during routine total hip arthroplasty (THA). This study was aimed at assessing early outcomes and learning curves of the SuperPATH approach in one Chinese hospital's experience. Early outcomes of the first consecutive 78 SuperPATH cases (80 hips) performed by the same surgeon were evaluated. The patients were divided into 4 groups according to the surgical order. The incision, intraoperative blood loss, hospital stay, Harris hip score, and complication occurrence in each group were evaluated. Learning curves were assessed using operative time and intraoperative blood loss as surrogates. The operation time and intraoperative blood loss of groups A and B were more than those of groups C and D, and the difference was statistically significant (P < 0.05); however, there was no statistically significant difference between the two groups (group A vs. group B, P = 0.426; group A vs. group B, P = 0.426). There was no statistically significant difference in terms of incision length and hospital stay, and Harris hip score at the last follow-up was increased with statistically significant difference when compared with that preoperatively among the 4 groups. One case of periprosthetic fracture occurred in group A. No other complication, such as joint dislocation, sciatic nerve injury, prosthesis loosening, periprosthetic infection, and deep vein thromboembolism, occurred in the 4 groups. In summary, for surgeons who are familiar with the standard posterolateral approach, they could achieve more familiarity with SuperPATH after 40 cases of surgery.Entities:
Mesh:
Year: 2020 PMID: 32964033 PMCID: PMC7492896 DOI: 10.1155/2020/5180458
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Comparison of baseline characteristics of patients in four groups.
| Characteristics | Group A ( | Group B ( | Group C ( | Group D ( |
|
|---|---|---|---|---|---|
| Sex (male/female) | 8/12 | 8/11 | 6/13 | 8/12 | 0.443 |
| Mean age (years) | 60.40 ± 9.60 | 62.40 ± 15.62 | 69.35 ± 10.04 | 65.75 ± 11.42 | 0.98 |
| BMI (kg/m2) | 24.26 ± 2.84 | 24.21 ± 2.63 | 24.43 ± 3.13 | 25.34 ± 2.80 | 0.57 |
| Diagnosis (femoral neck fracture/femoral head necrosis), case | 9/11 | 12/8 | 12/8 | 10/10 | 0.715 |
Comparison of clinical indicators of learning curve in four groups.
| Characteristics | Group A ( | Group B ( | Group C ( | Group D ( |
|
|---|---|---|---|---|---|
| Operative time (mins) | 122.65 ± 27.45 | 100.40 ± 8.65 | 82.85 ± 5.44 | 79.00 ± 8.22 | ≤0.001 |
| Intraoperative blood loss (ml) | 522.00 ± 346.97 | 359.00 ± 111.96 | 201.50 ± 60.80 | 180.00 ± 47.46 | ≤0.001 |
| Length of incision (cm) | 8.01 ± 0.77 | 7.81 ± 0.22 | 7.69 ± 0.49 | 7.71 ± 0.50 | 0.224 |
| Hospital stay (days) | 12.00 ± 4.72 | 11.60 ± 4.27 | 11.60 ± 4.21 | 10.58 ± 4.16 | 0.860 |
Figure 1Learning curve of the SuperPATH approach with operative time as a parameter, showing that approximately 40 cases reached asymptotes.
Figure 2Learning curve of the SuperPATH approach with intraoperative blood loss as a parameter, showing that approximately 40 cases reached asymptotes.
Figure 3(a) Preoperative X-ray of a 59-year-old female patient with right femoral neck fracture. (b) The results of X-ray showed that intraoperative periprosthetic fracture occurred (red arrow). (c) The results of X-ray 3 months after surgery showed that the reconstruction of the leg length and offset of hip joint was good. (d) X-ray at 6 months after surgery. (e) The pictures showed good function and stable hip joint.
Figure 4(a) Preoperative X-ray of a 69-year-old male patient with bilateral femoral head necrosis ARCO IV (HIV patients) who underwent bilateral SuperPATH approach. (b) The results of X-ray 1 week after surgery showed that the reconstruction of the length and eccentricity of both lower limbs was good. (c) X-ray at 6 months after surgery.
Clinical efficacy evaluation of the 4 groups of patients before and at the last follow-up.
| Group | Harris hip score |
|
| |
|---|---|---|---|---|
| Preoperative | Last follow-up | |||
| Group A ( | 32.39 ± 14.66 | 92.33 ± 4.75 | 18.942 | ≤0.001 |
| Group B ( | 30.25 ± 18.79 | 94.13 ± 4.25 | 16.916 | ≤0.001 |
| Group C ( | 31.53 ± 20.13 | 94.25 ± 3.10 | 14.907 | ≤0.001 |
| Group D ( | 31.61 ± 18.88 | 94.30 ± 2.61 | 14.688 | ≤0.001 |